The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 2, 2014, Pages 190-197

  Marquine, María J ^a   Umlauf, Anya ^a   Rooney, Alexandra S ^a   Fazeli, Pariya L ^a   Gouaux, Ben D ^a   Woods, Steven Paul ^a   Letendre, Scott L ^b   Ellis, Ronald J ^c   Grant, Igor ^a   Moore, David J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Anemia; Cognition; Cohort study; Comorbidity; HIV

Indexed keywords

HEMOGLOBIN; INTERLEUKIN 6; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AGING; ANEMIA; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CHRONIC LUNG DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EFFECT SIZE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXECUTIVE FUNCTION; FEMALE; HEPATITIS C; HIGH RISK POPULATION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FUNCTION; LEARNING; LIVER FUNCTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; MIXED INFECTION; MORTALITY; MOTOR PERFORMANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECALL; SCORING SYSTEM; SUBSTANCE USE; VETERAN; VETERANS AGING COHORT STUDY INDEX; WESTERN BLOTTING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGING; AIDS DEMENTIA COMPLEX; CALIFORNIA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; VETERANS; YOUNG ADULT;

EID: 84893774157     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000008     Document Type: Article

References (48)

1. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:288-292.
2. May MT, Sterne JAC, Costagliola D, et al. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet. 2006;368: 451-458.
3. Justice AC, McGinnis KA, Skanderson M, et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2010;11:143-151.
4. Justice AC, Freiberg MS, Tracy R, et al. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis. 2012;54:984-994.
5. Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27:563-572.
6. Justice AC, S PM, Tate JP, et al. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr. 2013; 62:149-163.
7. Justice AC, Tate JP, Freiberg MS, et al. Role of the veterans aging cohort study index in assessing total atherosclerotic burden Reply. Clin Infect Dis. 2012;55:751-752.
8. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3-16.
9. Heaton RK, Clifford DB, Franklin DR, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study. Neurology. 2010;75:2087-2096.
10. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIVinfected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:S19-S25.
11. Marcotte TD, Wolfson T, Rosenthal TJ, et al. A multimodal assessment of driving performance in HIV infection. Neurology. 2004;63:1417-1422.
12. Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIVassociated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317-331.
13. Tozzi V, Balestra P, Galgani S, et al. Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retroviruses. 2003;19:643-652.
14. Tozzi V, Balestra P, Murri R, et al. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS. 2004;15:254-259.
15. Ellis RJ, Deutsch R, Heaton RK, et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch Neurol. 1997;54: 416-424.
16. Wilkie FL, Goodkin K, Eisdorfer C, et al. Mild cognitive impairment and risk of mortality in HIV-1 infection. J Neuropsychiatry Clin Neurosci. 1998;10:125-132.
17. Cysique LA, Murray JM, Dunbar M, et al. A screening algorithm for HIV-associated neurocognitive disorders. HIV Med. 2010;11:642-649.
18. Stern Y, McDermott MP, Albert S, et al. Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol. 2001;58:473-479.
19. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals - the Hawaii Aging with HIV-1 Cohort. Neurology. 2004;63:822-827.
20. Cherner M, Ellis R, Lazzaretto D, et al. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS. 2004; 18:S27-S34.
21. Tate DF, DeLong A, McCaffrey DE, et al. Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients. Arch Clin Neuropsychol. 2011;26:614-623.
22. Sacktor N, Skolasky RL, Tarwater PM, et al. Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology. 2003;61:567-569.
23. Mcarthur JC, Hoover DR, Bacellar H, et al. Dementia in Aids patients - incidence and risk-factors. Neurology. 1993;43:2245-2252.
24. Cherner M, Letendre S, Heaton RK, et al. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology. 2005;64:1343-1347.
25. Hinkin CH, Castellon SA, Levine AJ, et al. Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis. 2008;27:11-17.
26. Ryan EL, Morgello S, Isaacs K, et al. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology. 2004;62:957-962.
27. Becker JT, Kingsley L, Mullen J, et al. Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology. 2009;73:1292-1299.
28. Yaffe K, Ackerson L, Tamura MK, et al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58:338-345.
29. McCrea M, Cordoba J, Vessey G, et al. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol. 1996;53:758-763.
30. Sorrell JH, Zolnikov BJ, Sharma A, et al. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci. 2006;60:174-181.
31. Rippeth JD, Heaton RK, Carey CL, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10:1-14.
32. Heaton RK, Grant I, Butters N, et al. The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995;1:231-251.
33. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26:759-778.
34. Cysique LA, Franklin D, Abramson I, et al. Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol. 2011;33: 505-522.
35. Cherner M, Suarez P, Lazzaretto D, et al. Demographically corrected norms for the Brief Visuospatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.-Mexico border region. Arch Clin Neuropsychol. 2007; 22:343-353.
36. Heaton RK, Miller S, Taylor M, et al. Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African Americans and Caucasian Adults. Lutz, FL: Psychological Assessment Resources; 2004.
37. Carey CL, Woods SP, Gonzalez R, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26:307-319.
38. Beck AT, Erbaugh J, Ward CH, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
39. Beck AT, Steer RA, Ball R, et al. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess. 1996; 67:588-597.
40. World Health Organization. Composite International Diagnostic Interview. Geneva, Switzerland: WHO; 1997.
41. First MB, Spitzer RL, Miriam G, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCIDI/ P). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
42. Hasin DS, Trautman KD, Miele GM, et al. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry. 1996;153: 1195-1201.
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
44. Ellis RJ, Badiee J, Vaida F, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011;25:1747-1751.
45. Bhaskaran K, Mussini C, Antinori A, et al. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. 2008;63: 213-221.
46. Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci. 2010;1207:155-162.
47. Lyons JL, Uno H, Ancuta P, et al. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr. 2011;57:371-379.
48. Heaton RK, Cysique LA, Jin H, et al. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol. 2008;14:536-549.